The Conversation Weekly

For much of the 21st century, one theory has dominated research efforts to cure Alzheimer's disease: the amyloid hypothesis. Beta-amyloid is a protein that builds up in clumps, or plaques, in the brains of people with Alzheimer's disease and is linked to their cognitive decline. But in recent years, despite the emergen

Three months after the Trump administration made drastic cuts to its aid agency, USAID, the effects are being felt across the world, particularly in Africa. In this episode we speak to Bright Simons, an African aid expert and visiting senior fellow at ODI Global about where the decimation of US aid leaves the debate ab

Liverpool FC just won the English Premier League. Contributing to their 5-1 victory over Tottenham to seal the title was Mohamed Salah, the Egyptian superstar who is the league's top scorer in the 2024-5 season. We're revisiting an episode that we first ran in December 2022 about research which used Salah to demonstrat

The Trump administration’s cuts to funding for American universities and research have left many scientists reeling and very worried. At the National Institutes of Health, which has an annual budget of US$47 billion to support medical research both in the U.S. and around the world, nearly 800 grants have been terminate

Few places on earth are immune to the explosion of anti-vaccination conspiracy theories and health disinformation fuelled by the COVID pandemic. But in countries like Brazil, where the disinformation flowed from the very top of government, the problem is even more acute and some people are exploiting the fear of others

The Birkin bag made by French luxury retailer Hermès has become a status symbol for the global elite. Notoriously difficult to obtain, the world's rich obsess over how to get their hands on one. But when US retailer Walmart recently launched a much cheaper bag that looked very similar to the Birkin, nicknamed a "Wirkin